FDA Advisers Unanimously Recommend Moderna’s Covid-19 Vaccine for Ages 6-17 Despite Data Showing High Risks of Heart Inflammation

Moderna’s COVID-19 vaccine may have a higher risk of heart inflammation than the Pfizer shot based on recent data, the U.S. Centers for Disease Control and Prevention said on Tuesday.

On Tuesday, the U.S. Food and Drug Administration met with its Vaccines and Related Biological Products Advisory Committee (VRBPAC) to discuss Moderna’s EUA request for a COVID-19 vaccine for children 6 through 17 years of age.

The same expert panel will meet again on Wednesday to discuss shots from Moderna and Pfizer for the kids under 5.

According to the CDC data, the incidence of heart inflammation was 4.41 excess per 100,000 who received the Pfizer/BioNTech for males aged 18-39 versus 6.27 excess cases per 100,000 for Moderna, Reuters reported.

Daniel Horowitz, the senior editor at The Blaze, tweeted on Monday regarding the side effects of the Moderna vaccine.

“Holy Moly! one-quarter of the kids in Moderna’s trial reported Grade 3 side effects, meaning they couldn’t go to school https://fda.gov/media/159189/download… So many had flu-like symptoms! Even the original strain of covid mainly did this to kids. Yet, we are giving them these symptoms upfront,” Horowitz tweeted.

The FDA called on speakers about their views on authorizing the Moderna vaccine for children ages 6 to 17. Some of the invited speakers were not in favor of the vaccine due to its life-threatening risks that completely ruined their lives.

Robyn Handsman was one of the speakers invited to share her first-hand experience with the experimental Moderna vaccine. Mrs. Handsman got her first Moderna shot on September 15, 2021. The following day, she woke up and her hands and arms were completely numb and tingly. Her blood pressure was also extremely high. After five days, her doctor informed her that she has protein in her urine. She was diagnosed also with permanent kidney damage.

https://www.thegatewaypundit.com/2022/06/update-fda-advisers-unanimously-recommend-modernas-covid-19-vaccine-ages-6-17-despite-data-showing-high-risks-heart-inflammation/